Answers are grounded in this paper and cite their sources.
OBJECTIVE: To analyze the clinical features and related factors of acquired resistance to EGFR-TKI in patients with non-small cell lung cancer (NSCLC) and brain metastases, and to construct a prognostic prediction model. METHODS: A total of 186 NSCLC patients were retrospectively enrolled and divided into four groups based on EGFR-TKI resistance and brain metastasis status: resistant with brain metastases (n = 65), resistant without brain metastases (n = 65), sensitive with brain metastases (n = 28), and sensitive without brain metastases (n = 28). Univariate and multivariate logistic regression analyses were used to identify independent risk factors for resistance. A Cox proportional hazards model was applied to evaluate prognostic factors, and ROC curves were used to assess the predictive performance of the model. RESULTS: Multivariate analysis showed that non-classical EGFR mutations, TP53 co-mutations, MET amplification, CEA >5 μg/L, and third-generation EGFR-TKI therapy were independently associated with resistance (all P < 0.05), while anti-angiogenic therapy significantly reduced the risk of resistance. The median overall survival (14.0 vs. 38.0 months) and progression-free survival (9.0 vs. 26.0 months) were significantly shorter in the resistant group (P < 0.001). The number of brain metastases ≥3, ECOG PS ≥2, and T790M negativity were independent predictors of poor prognosis. The combined prediction model demonstrated good discriminative ability, with an AUC of 0.81 (95% CI: 0.76-0.86). CONCLUSION: This study clarifies the factors associated with EGFR-TKI resistance and prognostic characteristics in NSCLC patients with brain metastases. The constructed prediction model helps identify high-risk patients and provides a reference for formulating individualized treatment strategies.
No takes yet. Share an insight, caveat, or question.
Wang et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: